theory clinical_105_6
imports Main

begin

typedecl entity
typedecl event

consts
  Trastuzumab :: "entity ⇒ bool"
  HER2 :: "entity ⇒ bool"
  HER2V777L :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  ExtracellularDomain :: "entity ⇒ bool"
  IntracellularDomain :: "entity ⇒ bool"
  IntracellularTyrosineKinaseDomain :: "entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  AntibodyTherapy :: "entity ⇒ bool"
  Location :: "entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Affect :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  Cause :: "event ⇒ bool"
  Located :: "event ⇒ bool"
  Target :: "event ⇒ bool"
  Specifically :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"
  Targeted :: "event ⇒ bool"  (* Added missing consts definition *)

(* Explanation 1: Trastuzumab binds specifically to the HER2 extracellular domain, and this binding does not affect mutations located in the intracellular kinase domain. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Trastuzumab x ∧ HER2 y ∧ ExtracellularDomain z ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Specifically e1 ∧ Affect e2 ∧ ¬Agent e2 x ∧ Patient e2 y ∧ Mutation y ∧ IntracellularDomain y"

(* Explanation 2: The HER2 V777L mutation is located in the intracellular tyrosine kinase domain, which is not targeted by trastuzumab. *)
axiomatization where
  explanation_2: "∃x y z e1. HER2V777L x ∧ Mutation y ∧ IntracellularTyrosineKinaseDomain z ∧ Located e1 ∧ Agent e1 y ∧ Patient e1 z ∧ ¬Targeted e1 ∧ Agent e1 x"

(* Explanation 3: This specific location directly leads to resistance to trastuzumab because trastuzumab does not target the intracellular domain. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Location x ∧ Resistance y ∧ Trastuzumab z ∧ Lead e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Directly e1 ∧ Target e2 ∧ ¬Agent e2 z ∧ Patient e2 x ∧ IntracellularDomain x"

(* Explanation 4: The HER2 V777L mutation may cause resistance to antibody therapy because it is located in the intracellular domain, which trastuzumab does not target. *)
axiomatization where
  explanation_4: "∃x y z e1 e2. HER2V777L x ∧ Mutation y ∧ Resistance z ∧ AntibodyTherapy z ∧ Cause e1 ∧ Agent e1 y ∧ Patient e1 z ∧ Located e2 ∧ Agent e2 y ∧ IntracellularDomain y ∧ Target e2 ∧ ¬Agent e2 x ∧ Patient e2 y"

(* Explanation 5: The location of the HER2 V777L mutation in the intracellular tyrosine kinase domain can lead to resistance to trastuzumab, as trastuzumab targets the extracellular domain and does not affect the intracellular domain. *)
axiomatization where
  explanation_5: "∃x y z w e1 e2 e3. Location x ∧ HER2V777L y ∧ Mutation y ∧ IntracellularTyrosineKinaseDomain z ∧ Resistance w ∧ Trastuzumab w ∧ Lead e1 ∧ Agent e1 x ∧ Patient e1 w ∧ Target e2 ∧ Agent e2 w ∧ Patient e2 y ∧ ExtracellularDomain y ∧ Affect e3 ∧ ¬Agent e3 w ∧ Patient e3 z ∧ IntracellularDomain z"

theorem hypothesis:
  assumes asm: "HER2V777L x ∧ Resistance y ∧ Trastuzumab z"
  (* Hypothesis: HER2 V777L may cause resistance to trastuzumab, as trastuzumab binds to the extracellular kinase domain, whereas the mutation is in the intracellular kinase domain. *)
  shows "∃x y z e1 e2. HER2V777L x ∧ Resistance y ∧ Trastuzumab z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ To y z ∧ Bind e2 ∧ Agent e2 z ∧ Patient e2 x ∧ ExtracellularDomain x ∧ IntracellularDomain x"
proof -
  (* From the known information, we have HER2V777L x, Resistance y, and Trastuzumab z. *)
  from asm have "HER2V777L x ∧ Resistance y ∧ Trastuzumab z" by blast
  (* Using Implies(C, E), we can infer Resistance y from HER2V777L x. *)
  then have "Resistance y" by blast
  (* Using Implies(C, D), we can infer that the HER2 V777L mutation is not targeted by trastuzumab. *)
  then have "¬Targeted e1" sledgehammer
  (* Using And(A, B), we know that trastuzumab binds specifically to the HER2 extracellular domain, and mutations located in the intracellular kinase domain are not affected by trastuzumab. *)
  then have "Bind e2 ∧ ExtracellularDomain x ∧ IntracellularDomain x" <ATP>
  (* Therefore, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
